The University of Chicago Header Logo

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO Rep. 2018 09; 19(9).

View in: PubMed